Replies to post #58840 on Easton Pharmaceuticals, Inc. (EAPH)

[User-65225]

AMFE is on pace for more revenue than EAPHs market cap... and EAPH valuation is very high at $25 million. Not including the billions of shares that are coming.

He had no choice but to raise the AS to 3 billion, recently. They plan to dump heavy into the news.

[Plowmaster]

I didn't think that was possible after all the big things I heard they were doing but its right there in the quarterly for EAPH



Zero, Zero, Zero.

How they going to pay for that manufacturing line they just said they would get done, regulated industry, extremely costly and time consuming. I guess no choice but to continue to dilute to 3 Billion A/S and then Reverse Split, start over.

Everything is wrong with this company

[Macod]

This can't be true ..can it??

EAPH revenues

FY2017 Q1: $0
FY2017 Q2: $0
FY2017 Q3: $0
FY2017 Q4: $0
FY2017 Total: $0

FY2018 Q1: $0
FY2018 Q2: $0
ALL 6 QUARTERS in total: $0